McKesson Corporation

MCK.F·Frankfurt
Compare
889.60+6.60 (+0.75%)today
As of Oct 19, 8:42 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close883.00
Open889.60
Day range—
52-week range611.60889.60
Off day high0.00%
Off 52-week high0.00%
Volume2.00
Avg. volume (3M)2.00
Market cap103.72B
EPS (TTM)32.00
Forward P/E41.73
P/E ratio (TTM)27.80
Dividend yield0.38% (3.32)
Beta (5Y)—
Shares outstanding116.59M
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
MCK.F CAH YI GSK CVS JNJ
Market cap 103.72B 57.96B 27.53M 99.42B 117.95B 612.87B
P/E (TTM) 27.8 34.6 0.3 15.7 24.3 38.6
Forward P/E 41.7 17.8 22.4 10.1 10.8 21.9
Price/book -27.3 -20.2 -0.2 4.2 1.5 7.2
Dividend yield 0.38% 0.81% — 3.67% 2.88% 2.10%
1-year change +30.54% +61.54% −28.86% +12.22% +11.98% +31.92%
Today +0.75% −1.48% +1.29% +0.23% −0.15% −0.49%

The closest companies by business and industry (Medical Distribution). Prices may be delayed up to 15 min.

Latest news

All MCK.F news ›
The Globe and Mail·Positive

Why McKesson (MCK) Stock Is Trading Up Today

Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 4.4% in the afternoon session after the company reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health…

Defense World·Positive

McKesson Corporation $MCK Shares Purchased by IFP Advisors Inc

IFP Advisors Inc lifted its position in McKesson Corporation (NYSE:MCK – Free Report) by 10.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned…

CNBC·

Cramer's lightning round: 'McKesson is a winner'

CNBC - It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed. X-Energy: "It's losing too much money. Since rates started rising, I…

modernhealthcare.com·Negative

McKesson CEO Hammergren will retire in 2019

John Hammergren is retiring after more than 17 years at the helm of the drug distributor. The company's current COO will take over as CEO, and the current lead independent director will take over as chairman. Chairman and CEO John…

Stock Titan·

McKesson officer proposes $797K share sale

An officer proposes selling 801 McKesson (MCK) shares valued at $797K. Stock Titan McKesson officer proposes $797K share sale The securities information lists 116,590,363 common shares outstanding alongside the proposed sale. Sentiment and…

@gurufocus·Positive

MCK Maintains by UBS -- Price Target Raised to $1200

On October 6, 2023, McKesson (MCK) received a Buy rating from UBS, with the price target adjusted from $1080.00 to $1200.00, reflecting an increase of 11.11% in the expected value of the stock. McKesson's strengths lie in its profitability…

From articles in the 4Search news index.

In the news

90mentions in 30 days
89with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 90 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.